RxDoctor Payments Data

Ana Emirzian, DPM

Foot & Ankle Surgery · Oxnard, CANPI 1609431964

Payments from drug & device makers

$9,496in general payments, 2019–2025

Across 73 payments — averaging $130.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Vilex LLC$1K
  • Supreme Orthopedic Systems, LLC$1K
  • Arthrex$1K
  • Anika Therapeutics, Inc.$499
  • Smith+Nephew$400
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$4,87251%
  • Food & beverage$3,42536%
  • Education$1,20013%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker14$3,066
Vilex LLC7$1,328
Supreme Orthopedic Systems, LLC2$1,220
Arthrex8$1,181
Anika Therapeutics, Inc.1$499
Smith+Nephew7$400
Exactech, Inc.2$295
Organogenesis Inc.6$288
Biotissue Holdings Inc.1$250
Treace Medical Concepts, Inc.2$211
Novus Surgical Solutions LLC1$186
Novastep Inc.4$139
Johnson & Johnson7$134
Medtronic2$82
Bioventus LLC2$60
Amgen(2 entities)2$50
Saxum Surgical, Inc.1$41
Painteq LLC1$21
Integra Lifesciences Corporation1$17
Paratek Pharmaceuticals, Inc.1$17
Orpyx Medical Technologies US Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,496 in reported general payments places this provider in the 80th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$78,672
Medicare patients
447
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox19$367
Meloxicam11$12

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Oxnard

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →